Erba Mannheim Launches Second Generation SARS-CoV-2 RT-PCR Assay with Room Temperature Storage

Erba Mannheim (London, UK) has launched the ErbaMDx SARS-CoV-2 RT-PCR Kit for the detection of SARS-CoV-2.

The ErbaMDx SARS-COV-2 RT-PCR kit is a molecular diagnostic test that aids the detection and diagnosis of COVID-19 infections and is based on latest nucleic acid amplification technologies. It is a real-time reverse transcriptase PCR test that has been developed utilizing universally trusted priming sites with updated primer sequences to maximize long term performance.


To overcome challenges in older COVID-19 molecular tests, Erba's Cambridge (UK)-based development team has carefully engineered the new assay to improve detection and ease of use with a single tube multiplex mastermix, compatible with room-temperature storage and transportation. The new assay offers 200 copies/ml LoD, using universally trusted gene targets highly specific for SARS-CoV-2 and updated primer sequences to maximize long term performance. Sample types include both nasopharyngeal and oropharyngeal swabs as well as saliva. The test has been validated for use with commonly available extraction kits and commonly available real time PCR analyzers. The CE-marked kit will be available through Erba's global distribution network.

"We are proud and excited to add a highly sensitive RT-PCR test to our growing range of immunoassay and molecular solutions," said Nikhil Vazirani, MD of Erba. "The new ErbaMDx SARS-CoV-2 test perfectly complements our successful COVID-19 IgG and IgM ELISA assays to offer customers a state-of-the-art molecular test in addition to antibody testing which will offer clinicians valuable insight into the immune response to infection or vaccination."

Related Links:
Erba Mannheim